https://scholars.lib.ntu.edu.tw/handle/123456789/518151
標題: | Pharmacological Management of Pediatric Pustular Psoriasis | 作者: | Huang Y.-W. TSEN-FANG TSAI |
公開日期: | 2020 | 出版社: | Adis | 卷: | 22 | 期: | 3 | 起(迄)頁: | 265-277 | 來源出版物: | Pediatric Drugs | 摘要: | Therapeutic management of pustular psoriasis remains a challenge despite the rapid advance in psoriasis research and the development of drugs, especially biologics. Treatment guidelines have been established for pustular psoriasis, but no controlled studies are present for juvenile pustular psoriasis (JPP). Search of the literature reveals that current evidence of JPP treatment is limited to case reports and case series. Among the conventional drugs for JPP, oral retinoid is the most commonly used, yet concerns for growth disturbance exist. Cyclosporine and methotrexate have also been administered as first-line treatment. Etanercept is the first biological agent approved for juvenile plaque psoriasis, followed by adalimumab. However, infliximab is usually recommended for JPP because of the rapidity of onset, despite not being approved for use in pediatric psoriasis patients. More recently, secukinumab, ixekizumab, brodalumab, guselkumab, and risankizumab have been approved for adult pustular psoriasis in selected countries. Controlled studies are needed to prove the efficacy and long-term safety of the therapeutic treatments currently used for JPP. ? 2020, Springer Nature Switzerland AG. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085959883&doi=10.1007%2fs40272-020-00383-6&partnerID=40&md5=73bd5050b0d523a3655f697ea6049d4e https://scholars.lib.ntu.edu.tw/handle/123456789/518151 |
ISSN: | 1174-5878 | DOI: | 10.1007/s40272-020-00383-6 | SDG/關鍵字: | antipsoriasis agent; apremilast; cyclosporine; interleukin 12; interleukin 17; interleukin 23; methotrexate; retinoid; tumor necrosis factor inhibitor; Article; childhood disease; drug efficacy; human; juvenile pustular psoriasis; photochemotherapy; phototherapy; practice guideline; priority journal; psoriasis vulgaris; pustular psoriasis; safety; systematic review; systemic therapy; topical treatment; child; psoriasis; Child; Humans; Psoriasis |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。